Six of the world’s most prestigious public drug discovery organisations are joining forces in a bid to improve the conversion rate of basic research into much-needed new therapies
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.